The efficacy and economic evaluation of roxadustat treatment for anemia in patients with kidney disease not receiving dialysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aimed to assess the efficacy, tolerance, and cost-effectiveness of roxadustat treatment for anemia in patients with chronic kidney disease not receiving dialysis (CKD ND).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Expert Rev Pharmacoecon Outcomes Res

Title: Expert review of pharmacoeconomics & outcomes research

Publisher: Informa UK Limited

ISSN (Electronic): 1744-8379

ISSN (Print): 1473-7167

Publication date (Electronic): Aug 2020

Volume: 20

Issue: 4

Affiliations

[1 ] Department of Pharmacy, The Second Affiliated Hospital of Soochow University , Suzhou, Jiangsu, China.

Article

DOI: 10.1080/14737167.2020.1747436

PubMed ID: 32249625

SO-VID: 68a928ac-316b-4327-94ab-0e89a255dd49

History

Keywords: meta-analysis,roxadustat,anemia,chronic kidney disease,Cost-effectiveness

Data availability:

Keywords: meta-analysis, roxadustat, anemia, chronic kidney disease, Cost-effectiveness

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 8

See all cited by